276 related articles for article (PubMed ID: 32591416)
1. Modulation of Major Human Liver Microsomal Cytochromes P450 by Component Alkaloids of Goldenseal: Time-Dependent Inhibition and Allosteric Effects.
McDonald MG; Tian DD; Thummel KE; Paine MF; Rettie AE
Drug Metab Dispos; 2020 Oct; 48(10):1018-1027. PubMed ID: 32591416
[TBL] [Abstract][Full Text] [Related]
2. Human cytochrome p450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components.
Chatterjee P; Franklin MR
Drug Metab Dispos; 2003 Nov; 31(11):1391-7. PubMed ID: 14570772
[TBL] [Abstract][Full Text] [Related]
3. An Integrative Approach to Elucidate Mechanisms Underlying the Pharmacokinetic Goldenseal-Midazolam Interaction: Application of In Vitro Assays and Physiologically Based Pharmacokinetic Models to Understand Clinical Observations.
Nguyen JT; Tian DD; Tanna RS; Arian CM; Calamia JC; Rettie AE; Thummel KE; Paine MF
J Pharmacol Exp Ther; 2023 Dec; 387(3):252-264. PubMed ID: 37541764
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory Effects of Dimethyllirioresinol, Epimagnolin A, Eudesmin, Fargesin, and Magnolin on Cytochrome P450 Enzyme Activities in Human Liver Microsomes.
Kim JH; Kwon SS; Jeong HU; Lee HS
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468305
[TBL] [Abstract][Full Text] [Related]
5. Characterization of dextromethorphan N-demethylation by human liver microsomes. Contribution of the cytochrome P450 3A (CYP3A) subfamily.
Gorski JC; Jones DR; Wrighton SA; Hall SD
Biochem Pharmacol; 1994 Jul; 48(1):173-82. PubMed ID: 8043020
[TBL] [Abstract][Full Text] [Related]
6. Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations.
Tanna RS; Tian DD; Cech NB; Oberlies NH; Rettie AE; Thummel KE; Paine MF
J Pharmacol Exp Ther; 2021 Jan; 376(1):64-73. PubMed ID: 33093187
[TBL] [Abstract][Full Text] [Related]
7. An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents.
Etheridge AS; Black SR; Patel PR; So J; Mathews JM
Planta Med; 2007 Jul; 73(8):731-41. PubMed ID: 17611934
[TBL] [Abstract][Full Text] [Related]
8. Assessing Transporter-Mediated Natural Product-Drug Interactions Via In vitro-In Vivo Extrapolation: Clinical Evaluation With a Probe Cocktail.
Nguyen JT; Tian DD; Tanna RS; Hadi DL; Bansal S; Calamia JC; Arian CM; Shireman LM; Molnár B; Horváth M; Kellogg JJ; Layton ME; White JR; Cech NB; Boyce RD; Unadkat JD; Thummel KE; Paine MF
Clin Pharmacol Ther; 2021 May; 109(5):1342-1352. PubMed ID: 33174626
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Inhibitory Effects of Synthetic Cannabinoid EAM-2201 on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
Kong TY; Kwon SS; Cheong JC; Kim HS; Kim JY; Lee HS
Molecules; 2018 Apr; 23(4):. PubMed ID: 29659506
[TBL] [Abstract][Full Text] [Related]
10. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes.
Gurley BJ; Gardner SF; Hubbard MA; Williams DK; Gentry WB; Khan IA; Shah A
Clin Pharmacol Ther; 2005 May; 77(5):415-26. PubMed ID: 15900287
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cytochrome P450 enzymes and uridine 5'-diphospho-glucuronosyltransferases by vicagrel in human liver microsomes: A prediction of potential drug-drug interactions.
Liu S; Wang Z; Chan E; Zhao Y; Kang J; Zhang X; Tian X
Chem Biol Interact; 2022 Jan; 352():109775. PubMed ID: 34910929
[TBL] [Abstract][Full Text] [Related]
12. Development of a method to determine cytochrome P450 1A2, 2C9, 2D6 and 3A4 activity sheep hepatic microsomes.
McBride GM; Soo JY; Varcoe T; Morrison JL; Wiese MD
J Pharmacol Toxicol Methods; 2020; 106():106934. PubMed ID: 33080390
[TBL] [Abstract][Full Text] [Related]
13. CYP3A5 Contributes significantly to CYP3A-mediated drug oxidations in liver microsomes from Japanese subjects.
Yamaori S; Yamazaki H; Iwano S; Kiyotani K; Matsumura K; Honda G; Nakagawa K; Ishizaki T; Kamataki T
Drug Metab Pharmacokinet; 2004 Apr; 19(2):120-9. PubMed ID: 15499178
[TBL] [Abstract][Full Text] [Related]
14. An ex vivo approach to botanical-drug interactions: a proof of concept study.
Wang X; Zhu HJ; Munoz J; Gurley BJ; Markowitz JS
J Ethnopharmacol; 2015 Apr; 163():149-56. PubMed ID: 25623616
[TBL] [Abstract][Full Text] [Related]
15. Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes.
Wen X; Wang JS; Neuvonen PJ; Backman JT
Eur J Clin Pharmacol; 2002 Jan; 57(11):799-804. PubMed ID: 11868802
[TBL] [Abstract][Full Text] [Related]
16. Effects of herbal products and their constituents on human cytochrome P450(2E1) activity.
Raner GM; Cornelious S; Moulick K; Wang Y; Mortenson A; Cech NB
Food Chem Toxicol; 2007 Dec; 45(12):2359-65. PubMed ID: 17658211
[TBL] [Abstract][Full Text] [Related]
17. Sorafenib and sunitinib, two anticancer drugs, inhibit CYP3A4-mediated and activate CY3A5-mediated midazolam 1'-hydroxylation.
Sugiyama M; Fujita K; Murayama N; Akiyama Y; Yamazaki H; Sasaki Y
Drug Metab Dispos; 2011 May; 39(5):757-62. PubMed ID: 21266595
[TBL] [Abstract][Full Text] [Related]
18. Goldenseal-Mediated Inhibition of Intestinal Uptake Transporters Decreases Metformin Systemic Exposure in Mice.
Oyanna VO; Garcia-Torres KY; Bechtold BJ; Lynch KD; Call MR; Horváth M; Manwill PK; Graf TN; Cech NB; Oberlies NH; Paine MF; Clarke JD
Drug Metab Dispos; 2023 Nov; 51(11):1483-1489. PubMed ID: 37562957
[TBL] [Abstract][Full Text] [Related]
19. Photochemistry and photocytotoxicity of alkaloids from Goldenseal (Hydrastis canadensis L.). 2. Palmatine, hydrastine, canadine, and hydrastinine.
Inbaraj JJ; Kukielczak BM; Bilski P; He YY; Sik RH; Chignell CF
Chem Res Toxicol; 2006 Jun; 19(6):739-44. PubMed ID: 16780351
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a Higher-Throughput Cytochrome P450 Inhibition Assay with the Novel Cofactor-Supplemented Permeabilized Cryopreserved Human Hepatocytes (MetMax Human Hepatocytes).
Palacharla VRC; Chunduru P; Ajjala DR; Bhyrapuneni G; Nirogi R; Li AP
Drug Metab Dispos; 2019 Oct; 47(10):1032-1039. PubMed ID: 31375472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
